Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Single-Arm, Single-Centre Efficacy and Safety Study of MHB088C for Injection in Patients With Advanced Extrapulmonary Neuroendocrine Cancer

NCT06951243 is registered in ClinicalTrials.gov with Beijing GoBroad Hospital as lead sponsor.

NCT NCT06951243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06951243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Single-Arm, Single-Centre Efficacy and Safety Study of MHB088C for Injection in Patients With Advanced Extrapulmonary Neuroendocrine Cancer
Lead sponsor
Beijing GoBroad Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
May 6, 2025
Completion date
May 6, 2028
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced extrapulmonary neuroendocrine cancer